Cadre X. Bees
FDA investigator
Appears on 1 document from 2023, mostly at sites in New Jersey. Most often cites what do I do if I receive a complaint about a PET drug product produced at my facility? (21 CFR 212.100(b)).
- 1
- Documents on file
- 4.0
- Observations per 483
- 2023
- First seen
- 2023
- Most recent
What they cite most
From 4 observations- 21 CFR 212.100(b)What do I do if I receive a complaint about a PET drug product produced at my facility?1
- 21 CFR 212.30(a)What requirements must my facilities and equipment meet?1
- 21 CFR 212.71(b)What actions must I take if a batch of PET drug product does not conform to specifications?1
- 21 CFR 212.80(d)What are the requirements associated with labeling and packaging PET drug products?1
Activity by year
2023: 1
Where
New Jersey 1
Is Cadre X. Bees coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2023-08-11 | 483 SOFIE Co. dba SOFIEAug 11, 2023 · Totowa, New Jersey | Totowa, New Jersey | 4 |
About this profile
What does Cadre X. Bees inspect?
Cadre X. Bees appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 212.100(b) (what do I do if I receive a complaint about a PET drug product produced at my facility?), followed by 21 CFR 212.30(a) and 21 CFR 212.71(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Cadre X. Bees is dated Aug 11, 2023.